BROOKLYN INNOSEQ INC.

Medtech · Private

Microbial screening test for early detection of gestational diabetes using microbiome biomarkers and machine learning

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$296K
Federal grants
$296K
1 award · 2024
Rank in peer group#12 of 68
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
4 pending

Capital timeline

2024FEDERAL ↑EQUITY ↓Cumulative $296K$296K
2024FEDERAL ↑EQUITY ↓Cumulative $296K$296K

Latest events

  • Federal grantHealth and Human S · Phase I · Development and Validation of a Non-Invasive Microbiome-Based Diagnostic Tool for Early Detection of Gestational Diabetes Mellitus$296K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 68 peers

Line = median

Medtech · Instrument

  • Federal grants#12 · top 18%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 4
  • PendingSystems And Methods Of Promoting Eubiosis In Pregnant Or Breastfeeding WomenUSPTOApplication 18218239
  • PendingSystems And Methods Of Promoting Eubiosis In Pregnant Or Breastfeeding WomenUSPTOApplication 17984602
  • PendingSystems And Methods Of Promoting Eubiosis In Pregnant Or Breastfeeding WomenUSPTOApplication PCTUS2021031839
Show all 4 patent records
  • Systems And Methods Of Promoting Eubiosis In Pregnant Or Breastfeeding WomenMar 7, 2024 · Application 18218239Pending
  • Systems And Methods Of Promoting Eubiosis In Pregnant Or Breastfeeding WomenApplication 17984602Pending
  • Systems And Methods Of Promoting Eubiosis In Pregnant Or Breastfeeding WomenApplication PCTUS2021031839Pending
  • Systems And Methods Of Promoting Eubiosis In Pregnant Or Breastfeeding WomenApplication 63022887Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .